Search Results 651-660 of 11369 for anti-TNF drugs
Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
This study aims to evaluate the impact of trilaciclib on myelopreservation and anti-tumor efficacy when administered prior to FOLFOXIRI/bevacizumab in ...
Immunosuppression strategies · Allograft vasculopathy. New areas of investigation include examining the potential role of anti-thrombotic therapy to prevent ...
Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous ...
The purpose of this study is to compare the effectiveness and safety of the humanized monoclonal anti ... Drugs used in chemotherapy, such as carmustine ...
Find out about symptoms and treatment of this liver disease. It's caused by exposure to certain substances, such as alcohol or medicines.
The April issue of Mayo Clinic Health Letter covers the risks of nonsteroidal anti-inflammatory drugs (NSAIDs) that include celecoxib (Celebrex), diclofenac ( ...
Prior anti-CD20 antibody or cytotoxic drugs may have been administered as single agents or as components of combination therapies. Each repeated course of ...
Drugs & Supplements · Healthy Lifestyle · Mayo Clinic ... treatment with SONALA-001 in combination with ... anti-tumor activity. Epidemiology Of Chronic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.